Infectiology

NCT05521568 – Diagnostic Accuracy of Rapid Molecular Tests for Group A Streptococcal Pharyngitis Using Saliva Samples

NCT06000527 – Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort  » REPA « )

NCT06158802 – Evaluation of Human Papillomavirus Vaccine Coverage in Girls and Young Women With Chronic Disease

NCT04361604 – Clinical Characterisation Protocol for COVID-19 in People Living With HIV (COVIDHIV)

NCT04357639 – Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP )

NCT04133012 – Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

NCT04867083 – Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week

NCT04844775 – A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

NCT05421286 – The MISTRAL Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events

NCT05149001 – Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma

NCT05222945 РA Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bict̩gravir Emtricitabine and t̩nofovir alaf̩namide

NCT04554914 – A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

NCT04554914 – A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

NCT04361604 – Clinical Characterisation Protocol for COVID-19 in People Living With HIV (COVIDHIV)

NCT04805203 – Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma

NCT04486885 – European Study of Cerebral Aspergillosis Treated With Isavuconazole

NCT05101187 – Olorofim Aspergillus Infection Study

From patients with chronic active Epstein Barr virus infection (CAEBV)

Patient cohort